EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY 4.0

Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study

Jon R Konradsen, Stina Selberg, Maria Ödling, Johanna Karlsson Sundbaum, Apostolos Bossios, Caroline Stridsman iD

Respirology · 2024-11 · 29 (11) · 942-950

DOI: 10.1111/resp.14774 ↗

At a glance

Kohortenstudie in Respirology, 2024-11. Written by Jon R Konradsen and 5 co-authors. Institution: Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. Major MEDLINE topics: Asthma, Anti-Asthmatic Agents. Cited 13 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Swedish Heart-Lung Foundation, Region Norrbotten, Region Stockholm.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Objective Uncontrolled asthma in patients treated for mild/moderate disease could be caused by non‐pulmonary treatable traits (TTs) that affect asthma control negatively. We aimed to identify demographic characteristics, behavioural (smoking) and extrapulmonary (obesity, comorbidities) TTs and the risk for future exacerbations among patients with uncontrolled asthma prescribed step 1–3 treatment according to the Global Initiative for Asthma (GINA).

Methods

Twenty‐eight thousand five hundred eighty‐four asthma patients (≥18 y) with a registration in the Swedish National Airway Register between 2017 and 2019 were included (index‐date). The database was linked to other national registers to obtain information on prescribed drugs 2‐years pre‐index and exacerbations 1‐year post‐index. Asthma treatment was classified into step 1–3 or 4–5, and uncontrolled asthma was defined based on symptom control, exacerbations and lung function.

Results

GINA step 1–3 included 17,318 patients, of which 9586 (55%) were uncontrolled (UCA 1–3). In adjusted analyses, UCA 1–3 was associated with female sex (OR 1.34, 95% CI 1.27–1.41), older age (1.00, 1.00–1.00), primary education (1.30, 1.20–1.40) and secondary education (1.19, 1.12–1.26), and TTs such as smoking (1.25, 1.15–1.36), obesity (1.23, 1.15–1.32), cardiovascular disease (1.12, 1.06–1.20) and depression/anxiety (1.13, 1.06–1.21). Furthermore, UCA 1–3 was associated with future exacerbations; oral corticosteroids (1.90, 1.74–2.09) and asthma hospitalization (2.55, 2.17–3.00), respectively, also when adjusted for treatment step 4–5.

Conclusion

Over 50% of patients treated for mild/moderate asthma had an uncontrolled disease. Assessing and managing of TTs such as smoking, obesity and comorbidities should be conducted in a holistic manner, as these patients have an increased risk for future exacerbations.

Subjects

MeSH terms (MEDLINE)

AsthmaAnti-Asthmatic AgentsHumansMaleFemaleMiddle AgedSwedenAdultCohort StudiesAgedRisk FactorsObesityDisease ProgressionRegistriesComorbiditySmokingYoung AdultAdolescent

Author keywords

asthma controlasthma treatmentcomorbiditiesexacerbationstreatable traitsuncontrolled asthma

Substances

Anti-Asthmatic Agents

Authors and institutions

  • Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Department of Public Health and Clinical Medicine/The OLIN-Unit, Umeå University, Umeå, Sweden.
  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Department of Health, Education and Technology, Luleå University of Technology, Luleå, Sweden.
  • Division of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID profiles: Caroline Stridsman

Funding

  • Swedish Heart-Lung Foundation
  • Region Norrbotten
  • Region Stockholm
  • Freemason Child House Foundation
  • the Konsul Th. C. Bergh's Foundation
  • Swedish Asthma and Allergy Association's Research Foundation
  • Paediatric Research Foundation of Astrid Lindgren Children's Hospital
  • Hjärt-Lungfonden

Cite

APA

Konradsen, J. R., Selberg, S., Ödling, M., Sundbaum, J. K., Bossios, A., & Stridsman, C. (2024). Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study. Respirology. https://doi.org/10.1111/resp.14774

Vancouver

Konradsen JR, Selberg S, Ödling M, Sundbaum JK, Bossios A, Stridsman C. Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study. Respirology. 2024. doi:10.1111/resp.14774

BibTeX
@article{Konradsen2024,
  author = {Konradsen, Jon R and Selberg, Stina and Ödling, Maria and Sundbaum, Johanna Karlsson and Bossios, Apostolos and Stridsman, Caroline},
  title = {Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study},
  journal = {Respirology},
  year = {2024},
  doi = {10.1111/resp.14774}
}
Start for free →